摘要
目的了解胰肾联合移植术后高钾血症的治疗研究进展,为胰肾联合移植术后预防和治疗高钾血症提供依据。方法复习近年来在胰肾联合移植术中关于高血钾治疗研究进展的相关文献并加以综述。结果目前研究证实,胰腺和肾脏通过不同方式维持血钾稳定,胰肾联合移植术后新移植的器官功能不全和移植术后用药均可引起高钾血症,针对不同原因采取对应的预防和治疗措施是胰肾联合移植术后高钾血症的治疗原则。结论胰肾联合移植术是治疗糖尿病肾功能衰竭的最佳治疗方式,术后高钾血症是其最常见的并发症之一,及时正确地对其处理对患者的生存及预后有着重要意义。
Objective To understand the research progress of treatment of hyperkalemia after simultaneous pancreas and kidney transplantation(SPK),and to provide the basis for the prevention and treatment of hyperkalemia after SPK.Method The relevant literatures about hyperkalemia after SPK in recent years were reviewed.Results The pancreas and kidney that maintained the stability of serum potassium in different ways had been confirmed in current studies.The newly transplanted organ dysfunction after SPK and the use of drugs after SPK both caused hyperkalemia.The treatment principle of hyperkalemia after SPK was to take corresponding prevention and treatment measures according to different reasons.Conclusions SPK is the best treatment for diabetic renal failure.Postoperative hyperkalemia is one of the most common complications,and timely and correct management is of great significance to the survival and prognosis of patients.
作者
胡逸涛
徐明清
LI Shifeng
HU Yitao;XU Mingqing;LI Shifeng(Organ Transplantation Center&Department of Liver Surgery,West China Hospital,Sichuan University,Chengdu 610041,P.R.China;Oklahoma Transplant Center,OU Medical Center,Oklahoma City,OK 73104,U.S.A.)
出处
《中国普外基础与临床杂志》
CAS
2021年第4期426-429,共4页
Chinese Journal of Bases and Clinics In General Surgery
关键词
胰肾联合移植
高血钾
钙调磷酸酶抑制剂
氟氢可的松
simultaneous pancreas and kidney transplantation
hyperkalemia
calcineurin inhibitor
fludrocortisone